Sunday, October 11, 2026

BTC $83,441 ▲ 0.64%

NewsLive Wire Politics World Markets Digital Assets Technology Sports

FranchisesThe Brief The Big Read The Breakdown Crypto Culture

MoreDeFi & On-Chain U.S. Equities Macro & Rates Research

LIVE

ADA$0.252+1.11%ETH$2,525+0.83%LINK$13.27+2.09%SOL$110.63+0.58%BTC$83,441+0.64%XRP$1.40+0.12%S&P 5007,812+0.59%Nasdaq27,366+0.64%Dow51,655+0.83%RUT2,807+0.46%TNX5.24%+0.25%TYX5.60%−0.11%FVX5.02%+0.60%IRX4.06%+0.35%VIX14.84−3.70%GOLD$4,216.30+0.00%SILVER$61.05+0.00%OIL$91.85+0.00%DXY102.23+0.02%NVDA$229.28−0.52%AAPL$336.64−1.11%TSLA$382.70+2.05%META$718.67−0.31%MSFT$535.07+2.38%AMZN$262.43+3.29%GOOGL$351.66+0.97%Fear & Greed61 — GreedADA$0.252+1.11%ETH$2,525+0.83%LINK$13.27+2.09%SOL$110.63+0.58%BTC$83,441+0.64%XRP$1.40+0.12%S&P 5007,812+0.59%Nasdaq27,366+0.64%Dow51,655+0.83%RUT2,807+0.46%TNX5.24%+0.25%TYX5.60%−0.11%FVX5.02%+0.60%IRX4.06%+0.35%VIX14.84−3.70%GOLD$4,216.30+0.00%SILVER$61.05+0.00%OIL$91.85+0.00%DXY102.23+0.02%NVDA$229.28−0.52%AAPL$336.64−1.11%TSLA$382.70+2.05%META$718.67−0.31%MSFT$535.07+2.38%AMZN$262.43+3.29%GOOGL$351.66+0.97%Fear & Greed61 — Greed

Tag

cancer

1 article

U.S. Equities2h ago

Moderna at $225: Melanoma Data and NIH Backing Justify Bull Case

Moderna has surged 600 percent in 2026 on melanoma vaccine efficacy and reported NIH support for personalized cancer vaccines, with analysts modeling $225 as fair value.